ZA919056B - Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia - Google Patents

Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

Info

Publication number
ZA919056B
ZA919056B ZA919056A ZA919056A ZA919056B ZA 919056 B ZA919056 B ZA 919056B ZA 919056 A ZA919056 A ZA 919056A ZA 919056 A ZA919056 A ZA 919056A ZA 919056 B ZA919056 B ZA 919056B
Authority
ZA
South Africa
Prior art keywords
hyperplasia
cardiac
treatment
vascular hypertrophy
hypertrophy
Prior art date
Application number
ZA919056A
Other languages
English (en)
Inventor
Holger Heitsch
Heitsch Holger
Wolfgang Linz
Linz Wolfgang
Hansjoerg Urbach
Urbach Hansjoerg
Rainer Henning
Henning Rainer
Bernward Schoelkens
Schoelkens Bernward
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA919056B publication Critical patent/ZA919056B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Recrystallisation Techniques (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA919056A 1990-11-17 1991-11-15 Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia ZA919056B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036706A DE4036706A1 (de) 1990-11-17 1990-11-17 Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie

Publications (1)

Publication Number Publication Date
ZA919056B true ZA919056B (en) 1992-07-29

Family

ID=6418475

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919056A ZA919056B (en) 1990-11-17 1991-11-15 Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

Country Status (20)

Country Link
US (1) US5236943A (zh)
EP (1) EP0492105B1 (zh)
JP (1) JP3370347B2 (zh)
KR (1) KR100221686B1 (zh)
CN (1) CN1049116C (zh)
AT (1) ATE108656T1 (zh)
AU (1) AU652590B2 (zh)
BR (1) BR9104918A (zh)
CA (1) CA2055637C (zh)
CZ (1) CZ283236B6 (zh)
DE (2) DE4036706A1 (zh)
DK (1) DK0492105T3 (zh)
ES (1) ES2060274T3 (zh)
HR (1) HRP940765B1 (zh)
HU (1) HU219404B (zh)
IE (1) IE66461B1 (zh)
MX (1) MX9102100A (zh)
NO (1) NO914482L (zh)
SK (1) SK280304B6 (zh)
ZA (1) ZA919056B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034114A (en) * 1990-12-14 2000-03-07 Smithkline Beecham Plc Medicament
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist
US5266583A (en) * 1992-09-01 1993-11-30 Merck & Co., Inc. Angitotensin II antagonist
NO304429B1 (no) * 1992-12-17 1998-12-14 Sankyo Co Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom
US5908858A (en) 1996-04-05 1999-06-01 Sankyo Company, Limited 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
PT946507E (pt) * 1996-12-10 2004-02-27 Searle & Co Compostos de pirrolilo substituidos para o tratamento da inflamacao
WO1998037068A1 (en) 1997-02-21 1998-08-27 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
AU2002341715A1 (en) * 2001-09-17 2003-04-01 Bristol-Myers Squibb Company Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
ITTO20040264A1 (it) * 2004-04-28 2004-07-28 Rotta Res Lab Spa Nuovi derivati pirrolici ad attivita' angiotensina-ii antagonista
EP1784398A1 (en) * 2004-09-02 2007-05-16 Teva Pharmaceutical Industries Ltd Purification of olmesartan medoxomil
WO2006029056A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Preparation of olmesartan medoxomil
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
US20060258727A1 (en) * 2005-01-03 2006-11-16 Lilach Hedvati Olmesartan medoxomil with reduced levels of impurities
EP2170062A4 (en) 2007-07-12 2010-12-29 Tragara Pharmaceuticals Inc METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER DISORDERS, TUMORS AND TUMOR-DISORDED DISEASES
DK2315590T3 (da) 2008-08-15 2012-11-19 N30 Pharmaceuticals Inc Pyrrolinhibitorer af S-nitrosoglutathionreduktase
WO2010019905A1 (en) 2008-08-15 2010-02-18 N30 Pharmaceuticals, Llc Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents
LT2318006T (lt) 2008-08-15 2017-01-10 Nivalis Therapeutics, Inc. Nauji s-nitrozoglutationo reduktazės pirolo inhibitoriai, kaip terapiniai agentai
CN102816126A (zh) * 2011-06-07 2012-12-12 中国药科大学 具有心血管活性的胺磺酰芳基取代的三氮唑类衍生物、其制备方法及用途
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US488084A (en) * 1892-12-13 Blank-feeding device
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
JPS5671073A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd Imidazole derivative
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
DE4023215A1 (de) * 1990-07-21 1992-01-23 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
DE4036645A1 (de) * 1990-11-16 1992-05-21 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung

Also Published As

Publication number Publication date
BR9104918A (pt) 1992-06-23
AU8785891A (en) 1992-05-21
HUT59599A (en) 1992-06-29
HRP940765A2 (en) 1997-08-31
JP3370347B2 (ja) 2003-01-27
MX9102100A (es) 1992-07-08
HU913581D0 (en) 1992-01-28
KR920009393A (ko) 1992-06-25
EP0492105A2 (de) 1992-07-01
ATE108656T1 (de) 1994-08-15
ES2060274T3 (es) 1994-11-16
CN1049116C (zh) 2000-02-09
HU219404B (hu) 2001-04-28
CS347191A3 (en) 1992-06-17
SK280304B6 (sk) 1999-11-08
AU652590B2 (en) 1994-09-01
DE4036706A1 (de) 1992-05-21
US5236943A (en) 1993-08-17
CN1062289A (zh) 1992-07-01
NO914482L (no) 1992-05-18
IE913992A1 (en) 1992-05-20
EP0492105B1 (de) 1994-07-20
DE59102259D1 (de) 1994-08-25
IE66461B1 (en) 1995-12-27
CA2055637A1 (en) 1992-05-18
HRP940765B1 (en) 2000-08-31
DK0492105T3 (da) 1994-11-07
EP0492105A3 (en) 1992-07-29
CA2055637C (en) 2003-11-11
JPH04290823A (ja) 1992-10-15
CZ283236B6 (cs) 1998-02-18
NO914482D0 (no) 1991-11-15
KR100221686B1 (ko) 1999-09-15

Similar Documents

Publication Publication Date Title
ZA919056B (en) Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
MY104140A (en) Substituted pyrrole, pyrazole and triazole angiotensin ii antagonists
ZA925698B (en) Treatment of congestive heart failure.
HUT62575A (en) Process for producing substituted imidazole derivatives and pharmaceutical compositions comprising same
MX9805628A (es) Imidazoles novedosos substituidos con cicloalquilo.
DE69816109D1 (de) Substituierte imidazole zur behandlung von entzündlichen krankheiten
DE69322254T2 (de) Pyridyl-substituierte imidazole
PH31175A (en) Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
AU8844491A (en) Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
GR3018826T3 (en) Hydantoin derivative.
HU9300942D0 (en) Imidazole derivatives, medical preparatives containing them as well as method for producing them
GB9125924D0 (en) Stereoisomers of an imidazole derivative
DK600788D0 (da) Triazol- eller imidazolforbindelser, fremgangsmaade til fremstilling deraf og anvendelse af saadanne forbindelser som fungicider
ZA975264B (en) Method for treating congestive heart failure.
ZA89126B (en) Substituted pyrrole,pyrazole and triazole angiotensin ii antagonists
IS1783B (is) Aðferð við framleiðslu á 1,2,3,9-tetrahýdró-9-metýl-3-[(2-metýl-1H-imídazól-1-ýl)metýl]-4H-karbasól-4-ón
EP0332306A3 (en) Preventing platelet loss using a thromboxane a2 receptor antagonist
ZA92703B (en) Imidazole,triazole and tetrazole derivatives
LTIP822A (en) Imidazole,triazole and tetrazole derivatives
MY108525A (en) Substituted imidazoles.
FI973845A (fi) Imidatsoli-, triatsoli- ja tetratsolijohdannaisia
AU644939C (en) Imidazole, triazole and tetrazole derivatives